Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06333171 · ClinicalTrials.gov registry record · Phase 2
4-aminopyridine for Skin Wound Healing
A Phase 2 study of Wounds and Injuries and Wound Heal, sponsored by John Elfar.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06333171: Recruiting Phase 2 study of Wounds and Injuries and Wound Heal, sponsored by John Elfar.
NCT06333171 is a Phase 2 study of Wounds and Injuries and Wound Heal that is actively recruiting participants, run by John Elfar. The registered enrollment target is 150 participants, below the 498-participant average among 27 other Wounds and Injuries trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06333171, a Phase 2 study of Wounds and Injuries and Wound Heal, is actively recruiting participants, sponsored by John Elfar.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Many patients suffer from chronic non-healing wounds as well as acute wounds. There is a need to develop treatments to accelerate and improve healing of chronic and acute wounds. More research is needed to evaluate the role of 4-aminopyridine (4-AP), a promising new agent with an excellent safety profile, on wound healing. The investigational treatment will be used to evaluate the role of (4-AP) on the treatment of wounds to accelerate wound healing in healthy adults. The purpose of this study is to evaluate the role of 4-AP on the treatment of wounds to accelerate healing. The investigational treatment will be used to test the hypothesis that 4-AP can speed wound healing.
Primary Outcome
Axillary skin punch biopsies will be performed on healthy volunteers. Wound healing will be measured using visual assessment.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG 4-Aminopyridine
Study Locations (1)
Arizona
- University of Arizona - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-09 |
| Est. Completion | 2028-03 |
| Phase | Phase 2 |
What NCT06333171 shows while recruiting
NCT06333171 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 498-participant average among 27 other Wounds and Injuries trials with a reported enrollment target (70% lower).
The record links to 4 conditions, with Wounds and Injuries appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06333171 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT06333171 about?
NCT06333171 is a clinical study titled "4-aminopyridine for Skin Wound Healing". Many patients suffer from chronic non-healing wounds as well as acute wounds. There is a need to develop treatments to accelerate and improve healing of chronic and acute wounds. More research is needed to evaluate the role of 4-aminopyridine (4-AP), a promising new agent with an excellent safety pr...
What is the current status of trial NCT06333171?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2025-09. Estimated completion is 2028-03.
What conditions does trial NCT06333171 study?
This clinical trial studies the following conditions: Wounds and Injuries, Wound Heal, Wound of Skin, Wounds.
What interventions are being tested in trial NCT06333171?
The interventions under investigation include: Placebo (OTHER), 4-Aminopyridine (DRUG).
Who is sponsoring clinical trial NCT06333171?
This trial is sponsored by John Elfar, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06333171 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wounds and Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06333171's enrollment target sits among peer trials
150 17th of 27 higher than 11 of 27 other Wounds and Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wounds and Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
4-Aminopyridine to Treat Skin Burns
RECRUITING · Phase 2
-
Human Penile Allotransplantation
RECRUITING · Phase 2
-
Human Upper Extremity Allotransplantation
RECRUITING · Phase 2
-
Feasibility Study for Fibroblast Autologous Skin Grafts
RECRUITING · Phase 2
-
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
RECRUITING · Phase 3
-
Effect of Giving Reduced Fluid in Children After Trauma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia